An in vitro study on HCT116 cells suggested that functionalizing PEGylated AuNPs with antibodies and chemotherapeutic drugs facilitated cellular internalization and triggered cancer cell death and that anti-CD133 mAb conjugates have potential as a targeted drug delivery system for colorectal cancer treatment. The gene discussed is PROM1; the disease is cancer.